Literature DB >> 1700994

Binding of IL-1 beta to alpha-macroglobulins and release by thioredoxin.

W Borth1, B Scheer, A Urbansky, T A Luger, L Sottrup-Jensen.   

Abstract

Human alpha 2-macroglobulin (H alpha 2M) is a major IL-1 beta binding plasma protein. The characteristics of the H alpha 2M IL-1 beta complex formation suggested, that cleavage of the internal thiol ester in other members of the alpha-macroglobulin family (alpha M) could enable these proteins to bind IL-1 beta. Characterization of optimal conditions for binding 125I IL-1 beta to H alpha 2M showed that H alpha 2M-IL-1 beta complex formation could be obtained over a pH range of 6.3 to 9 in the presence of some metal cations (i.e., Zn2+, Cd2+, Cu2+, Ni2+). Other divalent metal cations (i.e., Mn2+, Mg2+, Ca2+) were without effect. Time kinetic studies showed that binding of IL-1 beta to H alpha 2M was complete within 200 min and that H alpha 2M-IL-1 beta complexes became increasingly resistant to dissociation by boiling in SDS as a function of incubation time. Human pregnancy zone protein, rat alpha 1-, alpha 2-macroglobulin (R alpha 1M, R alpha 2M), all homologous with H alpha 2M, were tested for their ability to bind IL-1 beta. In each instance, alpha M-IL-1 beta complex formation was observed only after treatment of alpha M with methylamine, a primary amine that causes cleavage of the internal thiol ester in alpha M and the appearance of free thiol groups. Similarly, for each of these proteins, complex formation was increased several fold in the presence of Zn2+. Competition experiments using cytokines or proteins of similar molecular mass as IL-1 beta established that only unlabeled IL-1 beta was effective in inhibiting binding of 125I IL-1 beta to H"F" alpha 2M. Acylation of H"F" alpha 2M by diethylpyrocarbonate blocked the binding of IL-1 beta when analyzed by native PAGE. Deacylation of H"F" alpha 2M with hydroxylamine partially restored the binding capacity of H"F" alpha 2M further supporting the involvement of histidyl residues in the Zn2(+)-dependent binding of IL-1 beta. Reduced thioredoxin, but not its alkylated form, from Escherichia coli readily releases H"F" alpha 2M bound IL-1 beta under conditions that did not lead to reduction of disulfide bonds in H"F" alpha 2M. The action of thioredoxin also augmented IL-1-like activity in two independent bioassays suggesting that H"F" alpha 2M bound IL-1 beta is partially biologically inactive or latent. These results suggest that "activated" alpha M exert a modulating role for IL-1 beta by exposing specific binding sites, which are inaccessible in the native proteins.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700994

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Hypophyseal-pituitary-adrenal axis in autoimmune and rheumatic diseases.

Authors:  B H Athreya; P Rettig; W V Williams
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

2.  Expression of Panza, an alpha2-macroglobulin, in a restricted dorsal domain of the primitive gut in Xenopus laevis.

Authors:  Liliam Pineda-Salgado; Eileen J Craig; Rebecca B Blank; Daniel S Kessler
Journal:  Gene Expr Patterns       Date:  2005-11-07       Impact factor: 1.224

3.  A Survey on the Role of Interleukin-10 in Breast Cancer: A Narrative.

Authors:  Elnaz Sheikhpour; Parisa Noorbakhsh; Elnaz Foroughi; Soudabeh Farahnak; Rezvan Nasiri; Hossein Neamatzadeh
Journal:  Rep Biochem Mol Biol       Date:  2018-10

4.  Early supplemental α2-macroglobulin attenuates cartilage and bone damage by inhibiting inflammation in collagen II-induced arthritis model.

Authors:  Shengchun Li; Chuan Xiang; Xiaochun Wei; Xiaojuan Sun; Ruifang Li; Pengcui Li; Jian Sun; Dinglu Wei; Yong Chen; Yanxiang Zhang; Lei Wei
Journal:  Int J Rheum Dis       Date:  2019-01-04       Impact factor: 2.454

5.  Binding of platelet-derived growth factor-BB and transforming growth factor-beta 1 to alpha 2-macroglobulin in vitro and in vivo: comparison of receptor-recognized and non-recognized alpha 2-macroglobulin conformations.

Authors:  K P Crookston; D J Webb; J Lamarre; S L Gonias
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

6.  Identification of α2-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritis.

Authors:  Shaowei Wang; Xiaochun Wei; Jingming Zhou; Jing Zhang; Kai Li; Qian Chen; Richard Terek; Braden C Fleming; Mary B Goldring; Michael G Ehrlich; Ge Zhang; Lei Wei
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

7.  Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease.

Authors:  J S Hyams; J E Fitzgerald; N Wyzga; W R Treem; C J Justinich; D L Kreutzer
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

8.  Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase.

Authors:  R Mandel; H J Ryser; F Ghani; M Wu; D Peak
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Changes in tissue distribution of rat alpha 1-macroglobulin and pregnancy-associated alpha 1-glycoprotein after inflammatory injury.

Authors:  N A Zorin; S G Zhabin; T I Belogorlova; T S Chirikova; N A Krayushkina; O F Lykova
Journal:  Int J Exp Pathol       Date:  1994-12       Impact factor: 1.925

10.  Synthesis of a Cys949Tyr alpha 2-macroglobulin thiol ester mutant: co-transfection with wild-type alpha 2-macroglobulin in an episomal expression system.

Authors:  L Van Rompaey; H Van den Berghe; P Marynen
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.